AbbVie 2012 Annual Report Download - page 41

Download and view the complete annual report

Please find page 41 of the 2012 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 200

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190
  • 191
  • 192
  • 193
  • 194
  • 195
  • 196
  • 197
  • 198
  • 199
  • 200

EXECUTIVE OFFICERS OF THE REGISTRANT
The following table lists AbbVie’s executive officers, each of whom was appointed as an AbbVie
corporate officer in December 2012.
Name Age Position
Richard A. Gonzalez 59 Chairman of the Board and Chief Executive Officer
Laura J. Schumacher 49 Executive Vice President, Business Development, External
Affairs and General Counsel
William J. Chase 45 Executive Vice President, Chief Financial Officer
Carlos Alban 50 Executive Vice President, Commercial Operations
John M. Leonard, M.D. 55 Senior Vice President, Chief Scientific Officer
Timothy J. Richmond 46 Senior Vice President, Human Resources
Azita Saleki-Gerhardt, Ph.D. 49 Senior Vice President, Operations
Thomas A. Hurwich 52 Vice President, Controller
Mr. Gonzalez is AbbVie’s Chairman and Chief Executive Officer. He served as Abbott’s Executive
Vice President, Pharmaceutical Products Group from 2010 to 2012, and was responsible for Abbott’s
worldwide pharmaceutical business, including commercial operations, research and development, and
manufacturing. He has also served as President, Abbott Ventures Inc., Abbott’s medical technology
investment arm, from 2009 to 2011. Mr. Gonzalez joined Abbott in 1977 and held various management
positions before briefly retiring in 2007, including Abbott’s President and Chief Operating Officer,
President, Chief Operating Officer of Abbott’s Medical Products Group, Senior Vice President and
President of Abbott’s former Hospital Products Division (now Hospira, Inc.), Vice President and
President of Abbott’s Health Systems Division, and Divisional Vice President and General Manager for
Abbott’s Diagnostics Operations in the United States and Canada.
Ms. Schumacher is AbbVie’s Executive Vice President, Business Development, External Affairs
and General Counsel. She served as Abbott’s Executive Vice President, General Counsel, and
Corporate Secretary from 2007 to 2012, and as Senior Vice President, Corporate Secretary, and
General Counsel from 2005 to 2007. Ms. Schumacher was also responsible for Abbott’s licensing and
acquisitions function and its Office of Ethics and Compliance. Prior to her appointment as General
Counsel of Abbott, Ms. Schumacher headed Abbott’s litigation department. Ms. Schumacher joined
Abbott in 1990.
Mr. Chase is AbbVie’s Executive Vice President, Chief Financial Officer. He served as Abbott’s
Vice President, Licensing and Acquisitions from 2010 to 2012, as Vice President, Treasurer from 2007
to 2010, and as Divisional Vice President, Controller of Abbott International from 2004 to 2007.
Mr. Chase joined Abbott in 1989.
Mr. Alban is AbbVie’s Executive Vice President, Commercial Operations. He served as Abbott’s
Senior Vice President, Proprietary Pharmaceutical Products, Global Commercial Operations from 2011
to 2012, as Senior Vice President, International Pharmaceuticals from 2009 to 2011, as Vice President,
Pharmaceuticals, Western Europe and Canada from 2008 to 2009, as Vice President, Western Europe
and Canada from 2007 to 2008, and as Vice President, European Operations from 2006 to 2007.
Mr. Alban joined Abbott in 1986.
Dr. Leonard is AbbVie’s Senior Vice President, Chief Scientific Officer. He served as Abbott’s
Senior Vice President, Pharmaceuticals, Research and Development from 2008 to 2012, and as Vice
President, Global Pharmaceutical Research and Development from 2006 to 2008. Dr. Leonard joined
Abbott in 1992.
35